Overview

• Loomer’s lobbying preceded the State Department’s halt of visitor visas for people from Gaza, with reporting that she raised concerns directly to Secretary of State Marco Rubio and publicly targeted the nonprofit HEAL Palestine.
• Her Oval Office meeting with President Trump in April was followed by departures from the National Security Council, and reporting cites additional firings at the NSA, the Justice Department and other offices after her attacks.
• Multiple White House officials now express fatigue and suspicion that her campaigns are shaped by outside interests, with Sarepta Therapeutics cited by unnamed aides as a possible influence, though no payments have been substantiated.
• The White House says Loomer holds no advisory role, while Trump has said he sometimes follows her recommendations and has publicly praised her as she continues to meet senior officials and operate a public tip line.
• Loomer’s targeting of health officials included the brief ouster of FDA vaccine chief Vinay Prasad before his reinstatement, and her aggressive tactics have drawn objections from prominent Trump allies such as Marjorie Taylor Greene and Lindsey Graham.